Ireland - English - HPRA (Health Products Regulatory Authority)

laboratoire aguettant - ephedrine hydrochloride - solution for injection in pre-filled syringe - 3 milligram(s)/millilitre - ephedrine

Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - ephedrine hydrochloride, quantity: 30 mg - injection, solution - excipient ingredients: sodium chloride; sodium citrate; citric acid; water for injections - ephedrine interpharma injection is indicated in the treatment of hypotension secondary to spinal anaesthesia.

Ireland - English - HPRA (Health Products Regulatory Authority)

ethypharm - ephedrine hydrochloride - solution for injection - 30 milligram(s)/millilitre - ephedrine

Kenya - English - Pharmacy and Poisons Board

ephedrine hydrochloride - nasal drops - each ml contains: ephedrine hcl 10 mg (1.0 % w/v) - ephedrine

Australia - English - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - ephedrine hydrochloride -

United States - English - NLM (National Library of Medicine)

cantrell drug company - ephedrine sulfate (unii: u6x61u5zeg) (ephedrine - unii:gn83c131xs) - ephedrine sulfate 10 mg in 1 ml

United States - English - NLM (National Library of Medicine)

andersen pharma llc - ephedrine sulfate (unii: u6x61u5zeg) (ephedrine - unii:gn83c131xs) - ephedrine sulfate 50 mg in 1 ml

United States - English - NLM (National Library of Medicine)

aurohealth llc - pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - pseudoephedrine hydrochloride 120 mg - nasal decongestant - temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies - temporarily relieves sinus congestion and pressure if you are now taking a prescription monoamine oxidase inhibitor (maoi) (certain drugs for depression, psychiatric or emotional conditions, or parkinson’s disease), or for 2 weeks after stopping the maoi drug. if you do not know if your prescription drug contains an maoi, ask a doctor or pharmacist before taking this product. - heart disease - high blood pressure - thyroid disease - diabetes - trouble urinating due to an enlarged prostate gland -  nervousness, dizziness, or sleeplessness occur - symptoms do not improve within 7 days or occur with a fever

United States - English - NLM (National Library of Medicine)

chain drug consortium, llc - pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - pseudoephedrine hydrochloride 120 mg - nasal decongestant - temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies - temporarily relieves sinus congestion and pressure

United States - English - NLM (National Library of Medicine)

akorn - ephedrine sulfate (unii: u6x61u5zeg) (ephedrine - unii:gn83c131xs) - ephedrine sulfate injection is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. none risk summary limited published data on the use of ephedrine sulfate are insufficient to determine a drug associated risk of major birth defects or miscarriage. however, there are clinical considerations [see clinical considerations ]. animal reproduction studies have not been conducted with ephedrine sulfate. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively. clinical considerations fetal/neonatal adverse reactions cases of potential metabolic acidosis in newborns at delivery with maternal ephedrine exposure have been reported in the literature. these